drugset / Trial / NCT02346253

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

NCT02346253

Completed 146 enrolled Stanford University
NaSingle-groupOpen-labelTreatment

Summary

This trial studies the side effects and how well high-dose brachytherapy works in treating patients with prostate cancer that has not spread to other parts of the body. Brachytherapy is a type of radiation therapy in which radioactive material sealed in needles, seeds, wires, or catheters is placed directly into or near a tumor and may be a better treatment in patients with prostate cancer.

Timeline

Start
2015-01-13
Primary completion
2021-12-14
Completion
2026-05-17

Drugs

EvaluationDrugModalityDoseRoute
Background Bicalutamide Other / unclassified Oral
Background Decapeptyl Unknown Intramuscular
Background Degarelix Other / unclassified Subcutaneous
Background Goserelin Other / unclassified Subcutaneous
Background Leuprolide Other / unclassified Intramuscular